Primary childhood ALL patients express AsnS very little or not at all because of epigenetic control by DNA methylation at the CpG islands in the promoter of AsnS. This prevents the accessibility of ATF4 to turn on its expression [31,32], thereby maintaining reduced levels of Asn and sensitivity to ASNase treatments. The gene discussed is ATF4; the disease is acute lymphoblastic leukemia.